Enhancement of peripheral alpha-receptor stimulation by blockade of "silent" beta receptors.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D003042:Cocaine / Q000494:pharmacology; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D008297:Male; D008643:Mesentery / Q000098:blood supply; D008729:Methoxamine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D011311:Pressoreceptors / Q000187:drug effects / Q000502:physiology; D011433:Propranolol / Q000494:pharmacology; D011984:Sensory Receptor Cells / Q000187:drug effects*; D012701:Serotonin / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology; D014666:Vasomotor System / Q000187:drug effects*
D013565:Sympatholytics; D013566:Sympathomimetics; D000804:Angiotensin II; D012701:Serotonin; D011433:Propranolol; D008729:Methoxamine; D003042:Cocaine; D009638:Norepinephrine; D004837:Epinephrine; D006145:Guanethidine